Mega Genomics Eyes Hong Kong IPO To Ride Growing Popularity of Genetic Testing
The genetic testing company is looking to raise up to $33 million in a Hong Kong IPO as its services become popular in China Key Takeaways: Mega Genomics is looking…
RELATED ARTICLES
-
Fresh test for cancer-screening firm Genetron after Nasdaq exit
GTH.US
-
Burning Rock narrows losses with drug research as new driver
BNR.US
-
Sinking Burning Rock faces de-listing. But could privatization bid come first?
BNR.US
- Margins ring alarm bells as 160 Health readies IPO
-
Profits recover at Alibaba Health but prognosis unclear
0241.HK
- China fertility drive delivers growth opportunity for IVF Hospital
- Shanghai Refire hitches ride on Beijing’s green ambitions train as it eyes Hong Kong IPO
Discover hidden China stock gems in our weekly newsletter